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ABSTRACT
The intestinal pathogen Clostridium difficile is an urgent public health threat that causes antibiotic-associated diarrhea and is a
leading cause of fatal nosocomial infections in the United States. C. difficile rates of recurrence and mortality have increased in
recent years due to the emergence of so-called “hypervirulent” epidemic strains. A great deal of the basic biology of C. difficile
has not been characterized. Recent findings that flagellar motility, toxin synthesis, and type IV pilus (TFP) formation are regu-
lated by cyclic diguanylate (c-di-GMP) reveal the importance of this second messenger for C. difficile gene regulation. However,
the function(s) of TFP in C. difficile remains largely unknown. Here, we examine TFP-dependent phenotypes and the role of
c-di-GMP in controlling TFP production in the historical 630 and epidemic R20291 strains of C. difficile. We demonstrate that
TFP contribute to C. difficile biofilm formation in both strains, but with a more prominent role in R20291. Moreover, we report
that R20291 is capable of TFP-dependent surface motility, which has not previously been described in C. difficile. The expression
and regulation of the pilA1 pilin gene differs between R20291 and 630, which may underlie the observed differences in TFP-me-
diated phenotypes. The differences in pilA1 expression are attributable to greater promoter-driven transcription in R20291. In
addition, R20291, but not 630, upregulates c-di-GMP levels during surface-associated growth, suggesting that the bacterium
senses its substratum. The differential regulation of surface behaviors in historical and epidemic C. difficile strains may contrib-
ute to the different infection outcomes presented by these strains.
IMPORTANCE
How Clostridium difficile establishes and maintains colonization of the host bowel is poorly understood. Surface behaviors of C.
difficile are likely relevant during infection, representing possible interactions between the bacterium and the intestinal environ-
ment. Pili mediate bacterial interactions with various surfaces and contribute to the virulence of many pathogens. We report
that type IV pili (TFP) contribute to biofilm formation by C. difficile. TFP are also required for surface motility, which has not
previously been demonstrated for C. difficile. Furthermore, an epidemic-associated C. difficile strain showed higher pilin gene
expression and greater dependence on TFP for biofilm production and surface motility. Differences in TFP regulation and their
effects on surface behaviors may contribute to increased virulence in recent epidemic strains.
Since the emergence in the early 21st century of so-called “hy-pervirulent” epidemic strains of Clostridium difficile, the intes-
tinal pathogen is now one of the most common causes of nosoco-
mial infections in the developed world (1–3). C. difficile is
transmitted between patients in the form of dormant spores. Dur-
ing passage through the digestive tract, the spores germinate into
actively growing vegetative cells upon exposure to specific nutri-
ents, such as primary bile salts and amino acids, including glycine,
cysteine, phenylalanine, and arginine (4–6). These cells do not
readily colonize a healthy human colon, but disruption of the
native microbiota creates a niche for C. difficile, making previous
antibiotic therapy the major risk factor for C. difficile infection
(CDI) (7). Vegetative C. difficile secretes glucosylating cytotoxins
that inhibit host actin polymerization and disrupt the tight junc-
tions that maintain the integrity of the intestinal epithelium. The
toxins result in an inflammatory immune response, with symp-
toms ranging from diarrhea to pseudomembranous colitis or sep-
sis (7–10). CDI is recalcitrant to therapy with multiple antibiotics
and has a high rate of recurrence, with 10 to 20% of patients
experiencing reemergent symptoms after cessation of treatment
(9, 11).
Infections caused by some strains associated with epidemics,
such as those of ribotype 027, have higher rates of recurrence and
death than those caused by historical C. difficile strains (3). The
exact genetic and biochemical bases of the increased virulence of
epidemic strains remain unclear. Differential regulation of toxin
production, acquisition of an additional actin-specific binary
toxin, higher levels of host inflammation, increased antibiotic re-
sistance, and/or increased spore formation may contribute to the
more severe disease caused by epidemic strains (10, 12–15). In
addition, some of the genetic differences between historical and
epidemic strains are located in genes that encode small RNAs
rather than proteins, suggesting that some of the differences ob-
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served between strains may result from differences in gene regu-
lation (16).
The small nucleotide second messenger cyclic diguanylate (c-
di-GMP) has emerged as an important regulator of virulence
genes in C. difficile. In many Gram-negative and Gram-positive
bacteria, c-di-GMP regulates the transition between motile and
sessile forms; c-di-GMP generally inhibits cellular motility and
promotes biofilm formation (17). c-di-GMP signaling is pre-
dicted to play important roles in C. difficile adaptation to its envi-
ronment, as nearly 1% of the historical C. difficile 630 (ribotype
012) genome is dedicated to c-di-GMP metabolism.C. difficile 630
encodes a total of 37 predicted diguanylate cyclase (DGC) and
phosphodiesterase (PDE) enzymes, which synthesize and de-
grade, respectively, c-di-GMP (17, 18). The catalytic abilities of
these enzymes have been independently assessed through heterol-
ogous expression in Vibrio cholerae and Bacillus subtilis, which
indicated that the majority (21 and 27 enzymes, respectively) are
catalytically active (19, 20). The remaining proteins may be active
in C. difficile or under conditions not tested. Thirty-one of the 37
predicted DGCs and PDEs are conserved in the epidemic strain
R20291 (ribotype 027), suggesting that the historical and epi-
demic strains employ similar, but not identical, c-di-GMP regu-
latory networks (19). c-di-GMP repression of flagellum-mediated
swimming motility and toxin biosynthesis has been demonstrated
in strain 630 and an erythromycin-sensitive derivative, 630erm,
in which predicted c-di-GMP metabolism genes are completely
conserved (18, 21–23). To date, swimming motility is the only
c-di-GMP-regulated trait that has been examined in R20291 (21).
In C. difficile 630/630erm, c-di-GMP promotes the extracel-
lular assembly of type IV pili (TFP) by positively regulating pilus
gene expression (24). Regulation occurs via a c-di-GMP-respon-
sive riboswitch that, in the presence of its ligand, promotes tran-
scription elongation of pilA1, which encodes the major pilin sub-
unit (24–26). In other bacterial species, TFP mediate surface
motility, bacterial adhesion to surfaces and other bacteria, biofilm
formation, and/or adherence to host cells (27–31). In C. difficile,
pilus gene expression promotes autoaggregation, a process that
has been proposed to contribute to biofilm formation in 630/
630erm (21, 24, 25). Consistent with this, C. difficile biofilm for-
mation is also stimulated by elevated c-di-GMP (25).
Bacteria employ various mechanisms to move over surfaces,
including host tissue. Some bacteria are capable of gliding over
surfaces without the use of extracellular appendages, either by
forming focal adhesion complexes with the substrate or by pas-
sively “sliding” apart during cell division (32). Many flagellated
bacteria secrete lubricating molecules known as surfactants and
increase flagellar biosynthesis in order to “swarm” across surfaces
in multicellular groups (32). Some bacterial species can swarm
only on soft, highly elastic surfaces and are immobilized by agar
concentrations greater than 1%, while others can swarm readily
on up to 3% agar (33). Other species display flagellum-indepen-
dent twitching or gliding motility, in which cells move across sur-
faces through cyclic extension, tethering, and retraction of TFP.
TFP-mediated motility has been studied almost exclusively in
Gram-negative bacteria. Orthologues of TFP biosynthesis genes
have been identified in clostridia and other Gram-positive species,
and TFP-dependent gliding has been characterized in Clostridium
perfringens (34–36).
In this study, we investigated the functions of TFP in surface
behaviors of C. difficile. We uncovered roles for TFP in biofilm
formation on plastic and motility on agar surfaces and observed
differences in TFP-dependent phenotypes between the historical
630 and the epidemic R20291 strains. Elevated intracellular c-di-
GMP promoted biofilm development and surface motility in both
strains, but to varying degrees and with differing dependence on
TFP. Moreover, R20291 and 630 differ in pilA1 pilin gene expres-
sion. The differences are attributable to higher pilA1 promoter
activity in R20291 and to the ability of R20291 to accumulate
c-di-GMP during surface-associated growth. Our results suggest
that C. difficile surface sensing and behaviors involve c-di-GMP
regulation of TFP formation, and these processes differ between
strains.
MATERIALS AND METHODS
Bacterial strains and growth conditions. Table S1 in the supplemental
material describes the bacterial strains used in this study. C. difficile strains
were grown at 37°C under anaerobic conditions in tryptone-yeast (TY)
medium or in filter-sterilized brain heart infusion (BHI) medium supple-
mented with 5% yeast extract (BHIS), as indicated (5, 21, 37). Escherichia
coli strains were grown in Luria-Bertani broth at 37°C with aeration.
When appropriate, the following antibiotics were used: 100 g/ml ampi-
cillin (Amp), 10 g/ml chloramphenicol (Cm), 10 g/ml thiamphenicol
(Tm), 100 g/ml kanamycin (Kan), 20 g/ml lincomycin (Linc), 2.5
g/ml erythromycin (Erm), 8 g/ml cefoxitin (Cef), and 250 g/ml cy-
closerine (Cyc). Nisin was used for induction of gene expression at final
concentrations of 0.01 to 5 g/ml, as indicated.
Strain construction. Table S2 in the supplemental material lists the
plasmids used in this study, and Table S3 in the supplemental material lists
the primers. Disruption of the R20291 pilB1 gene was performed with the
ClosTron approach, using a targeted group II intron adapted for clostridia
essentially as previous described, resulting in an insertion in the sense
orientation at position 795 of the R20291 pilB1 gene (24, 38, 39). The
ClosTron plasmid was mated with C. difficile R20291, together with the
helper plasmid pR702 (24). ClosTron integrants were selected on BHIS
agar plates containing lincomycin. The intron insertion was confirmed by
Southern blotting (see Fig. S1A in the supplemental material) and by PCR
with primers CD3512-795s-F and LCF439, as previously described (24).
Details of the Southern blotting methods are included in Fig. S1. By trans-
mission electron microscopy, the mutant was confirmed to lack TFP pro-
duction in response to c-di-GMP (for details, see Fig. S1C in the supple-
mental material).
Insertion of Pcpr-dccA into the C. difficile 630erm chromosome to
create strain 630erm::Pcpr-dccA was accomplished by amplifying the
Pcpr-dccA fusion from plasmid pDccA with primers SMB47F1 and
SMB47R1 (21). The resulting product was digested with SalI and SphI
(restriction sites were introduced by the primers) and ligated into simi-
larly digested pSMB47 to create pSMB47::Pcpr-dccA. pSMB47 is a suicide
vector that integrates into the conjugal transposon Tn916 by homologous
recombination. The pSMB47::Pcpr-dccA plasmid was transformed into B.
subtilis strain BS49, which contains the transposon Tn916 (40). pSMB47::
Pcpr-dccA was integrated into Tn916 by homologous recombination to
create the strain BS49 pSMB47::Pcpr-dccA (41). This strain was mated with
C. difficile 630erm by conjugation under anaerobic conditions on BHIS
plates containing 5 mM KNO3. Transformants in which Tn916::Pcpr-dccA
had integrated randomly into the 630erm chromosome were selected on
BHIS plates containing Erm, Cef, and Cyc (42). Integration was con-
firmed by PCR with primers PcprF and cd1420R.
To create the gusA reporter strains, the gusA gene was amplified from
E. coli JM109 genomic DNA using primers gusAF and gusAR. The gusA
product was digested with XbaI and SphI, restriction sites for which were
introduced by the PCR primers, and ligated into similarly digested
pMC123 to create pMC123::gusA. Next, the 374-bp region upstream of
the 630erm pilA1 open reading frame, which encompasses the ribosome
binding site, promoter (PpilA1), and 5= untranslated region (UTR) con-
Purcell et al.
566 jb.asm.org February 2016 Volume 198 Number 3Journal of Bacteriology
taining the Cdi2_4 riboswitch, were amplified from 630 genomic DNA
using primers pilA1sF1 and pilA1-gusA_R, yielding fragment PpilA1-UTR.
To obtain an equivalent fragment with a riboswitch blind to c-di-GMP
(24), an A70G mutation was introduced into the c-di-GMP binding ap-
tamer of Cdi2_4 by incorporating the nucleotide change into self-com-
plementary primers, pilA1sR1 and pilA1sF2. Primers pilA1sF1 and
pilA1R1, and pilA1sF2 and pilA1-gusA_R, were used to amplify two over-
lapping fragments, which were then spliced together by PCR, creating the
fragment PpilA1-UTR
A70G. The gusA gene was amplified from pMC123::
gusA using primers pilA1-gusA_F and gusAR, and then, translational fu-
sions to both PpilA1-UTR and PpilA1-UTR
A70G were created by splicing by
overlapping extension (pilA1-gusA_F and pilA1-gusA_R are self-comple-
mentary). The resulting PpilA1-UTR-gusA and PpilA1-UTR
A70G-gusA
products were cloned into the EcoRI and SphI sites of pMC123. The
plasmids pMC123::PpilA1-UTR-gusA and pMC123::PpilA1-UTR
A70G-gusA
were confirmed by PCR using primers pUCmcsF and m13r and by se-
quencing. The gluD promoter was amplified from 630 genomic DNA
using primers PgluDF and PgluDR and ligated into the pMC123 vector at
the EcoRI and KpnI sites to create pMC-PgluD. The pilA1 gene with the
native 5= UTR but no promoter was amplified from 630 genomic DNA
using primers pilA1sR2 and pilA1R and ligated into pMC-PgluD at the
KpnI and PstI sites to create pMC123::PgluD-UTR-pilA1. pMC123::PgluD-
UTRA70G-pilA1 was generated by splicing the PCR products of primers
pilA1sF1 and pilA1R, and pilA1sF2 and pilA1sR2, and ligating the result-
ing fragment into pMC-PgluD at the KpnI and PstI sites. Primers PgluDF
and pilA1-gusA_R were used to amplify the PgluD-UTR and PgluD-
UTRA70G fragments from these vectors. The gusA gene was amplified from
pMC123::gusA using primers pilA1-gusA_F and gusAR and then spliced
with both PgluD-UTR and PgluD-UTR
A70G by PCR. The resulting transla-
tional-fusion products, PgluD-UTR-gusA and PgluD-UTR
A70G-gusA, were
cloned into the EcoRI and SphI sites of pMC123. Sequences were con-
firmed by PCR using primers pUCmcsF and m13r and by sequencing.
Plasmids pMC-Pcpr, pDccA, and pDccA
MUT and the gusA reporter
constructs were transformed into C. difficile strains 630erm and R20291
via conjugation with HB101(pRK24) (21, 42). The gusA reporter plasmids
were likewise transformed into 630erm::Pcpr-dccA, which allowed simul-
taneous thiamphenicol-dependent maintenance of the gusA plasmids and
nisin induction of dccA. Transconjugants were selected on BHIS-Tm-Kan
agar and appeared after 48 h at 37°C. C. difficile strains containing the
desired plasmid were identified by PCR using primers pUCmcsF and
m13r.
Biofilm assays. Overnight (16- to 18-h) cultures of C. difficile were
diluted 1:100 in fresh BHIS containing 1% glucose (43). Plasmid-bearing
strains were grown in BHIS-Tm with 1% glucose. Where needed to induce
gene expression from the Pcpr promoter, nisin was included at the indi-
cated concentrations. Biofilms were grown at 37°C for 24 or 48 h, as
specified, in untreated tissue culture plates that had been allowed to equil-
ibrate in the anaerobic chamber for at least 72 h. For visualization and
quantification of biofilm production, the supernatants were first carefully
removed from the wells. The biofilms were then washed once in phos-
phate-buffered saline (PBS), stained for 30 min in 0.1% filtered crystal
violet, and washed twice in PBS. The dye was solubilized in 100% ethanol
and quantified at 570 nm. The data were analyzed using a two-way anal-
ysis of variance (ANOVA) test.
Surface motility assays. Aliquots (5 l) of overnight (16- to 18-h)
cultures were spotted onto BHIS-1% glucose with the indicated percent-
ages of agar. Plasmid-bearing strains were spotted onto plates also con-
taining 10 g/ml Tm to maintain the plasmids. When needed to induce
gene expression from the Pcpr promoter, nisin was added at the indicated
concentrations. The spots were allowed to dry, and then, the plates were
wrapped in plastic to minimize evaporation over the 5-day incubation. To
account for asymmetrical spreading across the plates, two measurements
of the diameter of each motility spot were taken and averaged: one mea-
surement of the largest possible diameter and one perpendicular measure-
ment (represented in Fig. S2 in the supplemental material). For each
strain, spots derived from five biologically independent cultures were
measured at 24-h intervals. The data were analyzed using a one-way anal-
ysis of variance test. The plates were photographed using a Syngene G:Box
imager.
RNA isolation and real-time PCR. To examine gene transcript levels
in liquid culture, overnight (16- to 18-h) cultures were diluted 1:40 in
BHIS-Tm and grown to early stationary phase (12 h), as described previ-
ously (44). When needed to induce dccA expression, nisin was included at
a final concentration of 1 g/ml. To measure transcript abundance in
biofilms, supernatants were carefully removed from biofilm samples to
serve as the planktonic fractions. The remaining biofilm fractions were
washed once with PBS and then manually dispersed by vigorously scrap-
ing the cells into PBS with 0.1% Tween (PBS-T) using a pipette tip. The
planktonic and biofilm fractions were immediately centrifuged to remove
the culture medium or PBS-T and preserved in 1:1 ethanol-acetate. RNA
was isolated, treated with DNase I, and reverse transcribed as previously
described (21, 45). Quantitative reverse transcriptase (qRT) PCR analyses
were done as described previously (21). Primers were designed using the
PrimerQuest tool from IDT Technologies, and we verified that the prim-
ers chosen are capable of amplifying the same sequences from 630erm
and R20291 genomic DNA. Control reaction mixtures lacking reverse
transcriptase were included for all templates and all primer sets. The data
were analyzed by using the 2CT method, expressed as the fold change
in the transcript level under the test conditions compared to the indicated
control and normalized to the reference gene rpoC (44). At least three
biologically independent samples were used for all analyses. The data were
analyzed using the statistical tests specified in the figure legends.
Transcriptional reporter assays. -Glucuronidase assays were per-
formed as previously described (46, 47). Overnight cultures of strains
630erm and R20291 containing the reporter plasmids were diluted 1:50
in BHIS medium and grown to an optical density at 600 nm (OD600) of
1.0, and then 1.0- and 0.1-ml samples were assayed for hydrolysis of
p-nitrophenol--D-glucuronide. For biofilm -glucuronidase assays,
overnight cultures were diluted 1:50 in fresh BHIS-Tm medium contain-
ing 1% glucose in 24-well untreated tissue culture plates and grown an-
aerobically at 37°C for 24 h. The planktonic fractions were collected, and
the remaining biofilms were washed once in anaerobic PBS and then
disrupted by vigorous scraping into fresh anaerobic PBS. Sample volumes
were normalized to the OD600 in order to ensure equivalent cell numbers
in the planktonic and biofilm samples. For assays using agar-grown cul-
tures, after 1, 3, or 5 days, cells were scraped from the agar surface into
anaerobic PBS and vortexed to homogeneity before the OD600 was mea-
sured. The -glucuronidase activities of all samples were normalized to
the culture volume assayed and the OD600. At least four biologically inde-
pendent samples were assayed, and the data were analyzed using two-way
ANOVA or the unpaired Student’s t test as indicated.
c-di-GMP quantification by ultraperformance liquid chromatogra-
phy coupled to mass spectrometry (UPLC-MS). Nucleotides were ex-
tracted from C. difficile for quantification as previously described (21).
Briefly, overnight cultures of 630erm and R20291 strains containing
pDccA were diluted 1:50 in BHIS-Tm medium with 0, 0.01, 0.1, or 1
g/ml nisin and grown to an OD600 of 1.0, and then, 50-ml cultures
were centrifuged for 10 min at 6,400  g in sealed 50-ml conical tubes.
Samples were returned to the anaerobic chamber, and cell pellets were
washed in 1 ml PBS, transferred to clean microcentrifuge tubes, and cen-
trifuged for 3 min at 1,000 g. The pellets were removed from the anaer-
obic chamber, suspended in 250l of extraction buffer (methanol-aceto-
nitrile-distilled H2O [dH2O] [40:40:20] plus 0.1 N formic acid), and
incubated at 20°C for 30 min. Samples were centrifuged at 12,000  g
for 5 min at 4°C, and 200-l aliquots of the supernatant were transferred
to clean tubes and immediately neutralized by adding 8l of 15% (wt/vol)
NH4HCO3. The total protein content of the nonsoluble fraction was
quantified using the colorimetric BCA protein assay kit (ThermoScien-
tific). Nucleotide samples were stored at 80°C until they were used.
Samples were dried by vacuum centrifugation in a Savant speed-vac and
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reconstituted in 100 l deionized water. Aliquots (10 l) were injected
into a TSQ Quantum Ultra triple-quadrupole mass analyzer (Thermo
Scientific, Waltham, MA) coupled to an Acquity UPLC separation system
(Waters Corporation, Milford, MA). The analytes were separated on a
Waters HSS T3 UPLC column (2.1 by 100 mm; 1.8 m) by gradient
elution from 99.9% solvent A (10 mM ammonium formate in water) to
40% solvent B (10 mM ammonium formate in methanol) for 2 min,
followed by column flushing at 90% solvent B for 2.5 min and column
reequilibration for 3.5 min. The column effluent was diverted to waste for
the first 2 min. Mass spectrometer parameters were as follows: positive ion
electrospray mode; spray voltage, 3.5 kV; vaporizer temperature, 250°C;
sheath gas, 35 arbitrary units; auxiliary gas, 30 arbitrary units; capillary
temperature, 285°C; collision gas pressure, 1.5 mtorr. c-di-GMP was de-
tected by monitoring precursor ion to fragment ion transitions (m/z 691
152 [collision energy, 35] and m/z 691 540 [collision energy, 21]) and
quantified using a calibration curve of pure c-di-GMP (Biolog Life Science
Institute, Bremen, Germany) at known concentrations over a range of 0.1
to 1,000 nM. Cytoplasmic c-di-GMP measurements were normalized to
the total protein content of the samples.
RESULTS
c-di-GMP regulates biofilm formation via TFP biosynthesis. We
previously reported that manipulation of C. difficile c-di-GMP
levels is possible through plasmid-based expression of the C. dif-
ficile diguanylate cyclase gene, dccA (21). This system uses a nisin-
responsive promoter to induce the production of DccA. Liquid
chromatography-mass spectrometry measurements of intracellu-
lar c-di-GMP confirmed that in C. difficile strain 630, dccA induc-
tion stimulates c-di-GMP synthesis in proportion to the amount
of nisin used (21). We repeated these experiments with C. difficile
strain R20291 and confirmed that R20291 exhibits the same dose-
dependent increase in the intracellular c-di-GMP concentration
upon nisin induction of plasmid-borne dccA (see Fig. S3 in the
supplemental material). Moreover, we determined that in the ab-
sence of nisin induction, the 630 derivative strain 630erm and
R20291 have comparable c-di-GMP levels (see Fig. S3 in the sup-
plemental material). Independent studies have shown that C. dif-
ficile strains 630 and 630erm (which is more amenable to cur-
rently available genetic approaches) produce more biofilm upon
dccA overexpression and that R20291 produces substantially more
biofilm than 630/630erm even in the absence of c-di-GMP ma-
nipulation (25, 43). The mechanisms by which R20291 forms
more robust biofilms and the role(s) of c-di-GMP in R20291 bio-
film formation have not been reported.
To determine whether c-di-GMP regulation of biofilm forma-
tion differs between 630/630erm and R20291, we examined bio-
film formation by these strains with artificially modified c-di-
GMP levels. We assayed biofilm production on plastic for both
strains carrying the control vector or the inducible dccA expres-
sion plasmid for manipulation of c-di-GMP (pDccA). C. difficile
630erm and R20291 with pDccAMUT, which allows nisin-induc-
ible expression of a dccA allele encoding an enzymatically inactive
diguanylate cyclase, were included as controls (21). Biofilm for-
mation in strains carrying the vector was indistinguishable from
that of the respective parental strains (data not shown). In addi-
tion, the presence of nisin did not itself alter biofilm production,
as demonstrated by the relatively consistent biofilms, with or
without nisin, for the control strains carrying the vector. Consis-
tent with previous reports (43), biofilm formation by R20291 was
9 times higher than that by 630erm (Fig. 1A). In 630erm, ex-
pression of dccA dramatically increased biofilm formation in a
dose-dependent manner, with measurable effects at 0.01 g/ml
nisin (Fig. 1A). Biofilm accumulation increased with the nisin
concentration until 1 g/ml nisin, for a maximum 10-fold in-
crease in biofilm formation (Fig. 1A). In contrast, R20291 biofilm
levels were not measurably affected by nisin concentrations of less
FIG 1 c-di-GMP regulation of TFP synthesis influences biofilm formation in 630
and R20291. Biofilm formation on plastic was measured by crystal violet staining
after 24 h of growth in BHIS-Tm. Shown are the means and standard deviations
for three biologically independent samples assayed. (A) Biofilm formation by
630erm and R20291 carrying vector, pDccA, or pDccAMUT in BHIS-Tm me-
dium containing increasing concentrations of nisin to achieve increasing intracel-
lular c-di-GMP levels. Biofilm measurements at each nisin concentration were
compared to biofilms formed by the same strain at 0 g/ml nisin by two-way
ANOVA and Tukey’s multiple comparisons. *, P	 0.05; **, P	 0.01; ****, P	
0.0001. (B) Biofilm formation by wild-type and gene-disrupted 630erm and
R20291 carrying control vector or pDccA in BHIS-Tm medium with 1 g/ml
nisin. Biofilm measurements of mutant strains were compared to those of their
respective wild-type backgrounds. The brackets indicate significantly different
comparisons. *, P	 0.05; ****, P	 0.0001, as determined by two-way ANOVA
using Tukey’s multiple comparisons. (C) Biofilm formation in the presence of 1
g/ml nisin by 630erm pDccA and the pilA1 mutant derivative carrying pDccA
or pDccA containing pilA1 expressed in trans under the control of the wild-type
riboswitch UTR (pDccA-RB-pilA1) or the mutant riboswitch (pDccA-RBA70G-
pilA1). n.s. not significant; *, P	 0.05; **, P	 0.01, as determined by one-way
ANOVA and Tukey’s multiple comparisons.
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than 1g/ml, which increased R20291 biofilm formation 3.7-fold
(Fig. 1A). This difference in nisin-induced biofilm formation was
not due to strain-specific differences in c-di-GMP production in
response to dccA expression (see Fig. S3 in the supplemental ma-
terial). Both strains showed maximal biofilm formation at 1g/ml
nisin, with no further increase at higher nisin concentrations, sug-
gesting that this condition enables the maximum c-di-GMP-in-
ducible biofilm production in each strain (Fig. 1A). In addition,
we observed no increases in biofilm formation for 630erm or
R20291 with pDccAMUT, regardless of the nisin concentration,
indicating that increases in biofilm formation are specifically
attributable to elevated c-di-GMP (Fig. 1A). The presence of
pDccAMUT actually decreased biofilm formation in R20291, al-
though the effect was independent of nisin. R20291 with vector
formed biofilms comparable to those of the parent strain, so the
decrease appears to be an effect of the dccAMUT gene product
rather than of the plasmid. As DGC enzymatic activity is predicted
to depend on protein dimerization (48, 49), it is possible that
overexpression of dccAMUT titrates the enzymatically active gene
products of the chromosomally encoded wild-type dccA into in-
active heterodimers or interferes with signaling pathways affecting
biofilm development through some other mechanism.
It was previously shown that c-di-GMP increases the expres-
sion of the pilA1 pilin gene and augments TFP production in C.
difficile 630erm (24). In addition, disruption of either the pilA1
structural pilin gene or pilB1, which is predicted to encode an
ATPase essential for pilin export and assembly, produces identical
phenotypes, abolishing c-di-GMP-stimulated TFP production in
this background (24). TFP in other bacteria participate in surface
adhesion and biofilm development. Thus, we hypothesized that
TFP contribute to c-di-GMP-induced biofilm formation in C. dif-
ficile (24, 27–29). To determine the role of TFP in biofilm forma-
tion, we assayed 630erm and R20291 pilus gene mutants for
biofilm formation on plastic. In 630erm with unaltered c-di-
GMP, neither a pilA1 nor a pilB1 mutation affected biofilm pro-
duction (Fig. 1B). Because wild-type 630erm does not produce
substantial biofilm under these conditions, we also examined the
effect of the pilA1 and pilB1 mutations in 630erm with elevated
c-di-GMP, which produces significantly more biofilm (Fig. 1A).
In this case, disruption of pilA1 or pilB1 significantly reduced c-di-
GMP-induced biofilm formation to 39% and 54% of wild-type
levels, respectively, but did not completely abolish it (Fig. 1B).
These results indicate that under biofilm-inducing conditions
(i.e., high c-di-GMP), TFP contribute to biofilm formation, but
additional factors also play a role.
Because the pilB1 gene is the first gene in a 10.9-kb operon, the
ClosTron insertion is likely to have polar effects on the down-
stream genes. The pilB1 mutant is thus a pilB1 operon mutant
rather than specifically an assembly ATPase mutant. Genes down-
stream of pilB1, such as the prepilin peptidase gene pilD (24), are
also important for proper TFP biosynthesis; thus, complementa-
tion with the pilB1 gene alone is unlikely to restore the wild-type
phenotype. Due to the size of the operon, we did not attempt to
complement the pilB1 operon mutation. We instead focused on
complementation of the mutation of pilA1, which is transcribed
separately under the control of the c-di-GMP-responsive ribo-
switch, Cdi2_4 (24). Complementation was done using pDccA as
the vector backbone to allow manipulation of intracellular c-di-
GMP. As described previously (24), the pilA1 gene was cloned into
this plasmid under the control of the native promoter and 5= UTR
containing Cdi2_4 (pDccA-RB-pilA1) or under the control of the
native promoter and the 5= UTR containing an A70G mutation in
Cdi2_4 (pDccA-RBA70G-pilA1). The A70G mutation greatly re-
duces Cdi2_4 affinity for c-di-GMP, yielding a riboswitch that is
essentially blind to c-di-GMP and prevents the expression of the
downstream gene in response to increases in c-di-GMP (24).
Upon increasing intracellular c-di-GMP through nisin-induced
dccA expression, expression of pilA1 in trans under the control of
the wild-type riboswitch UTR (pDccA-RB-pilA1) restored biofilm
formation of the pilA1 mutant to that of wild-type 630erm with
high c-di-GMP (Fig. 1C). In contrast, expression of pilA1 in trans
under the control of the mutant riboswitch (pDccA-RBA70G-
pilA1) failed to complement biofilm formation by the pilA1 mu-
tant. These results support the conclusion that pilA1 participates
in C. difficile biofilm formation in a c-di-GMP-dependent man-
ner.
We were unable to obtain a ClosTron insertion in pilA1 in
R20291, but we successfully disrupted pilB1 (see Fig. S1A in the
supplemental material). As in 630erm, increasing c-di-GMP
through dccA expression in R20291 led to the production of sur-
face structures 8 to 9 nm in diameter, consistent in size with TFP
(typically 5 to 7 nm) (see Fig. S1B in the supplemental material)
(30). The Targetron insertion in pilB1 eliminated the appearance
of the structures (see Fig. S1C in the supplemental material). As
the pilA1 and pilB1 mutations result in the same phenotypes in
630erm, we used the R20291 pilB1 mutant strain to assess the
effects of diminished TFP biosynthesis on biofilm formation in
the strain. In contrast to the results seen in 630erm, disruption of
the pilB1 gene in R20291 reduced biofilm formation significantly
compared to that produced by wild-type R20291 in the absence of
c-di-GMP manipulation. Moreover, pilB1 disruption in R20291
eliminated c-di-GMP-induced increases in biofilm formation
(Fig. 1B). These findings indicate that TFP make a greater contri-
bution to biofilm development in R20291 than in 630erm.
R20291 and 630erm exhibit distinct pilA1 expression pro-
files between planktonic and biofilm growth. We next postulated
that because R20291 appears to rely more heavily on TFP for bio-
film formation than 630erm, the two strains might differ in their
expression of TFP genes in planktonic and/or biofilm culture. We
therefore compared the transcript levels of all the predicted C.
difficile pilin genes in planktonic and biofilm-grown wild-type C.
difficile of both strains using qRT-PCR. The genes encoding
known or putative pilins are all at least 94% identical between C.
difficile 630 and R20291 (see Table S4 in the supplemental mate-
rial) (50). As a control in these studies, the transcript level of the
codY gene was measured and determined not to differ between
biofilm and planktonic conditions in either strain (Fig. 2). Tran-
scripts of pilA5 and pilA6, which are predicted to encode minor
pilins, were detectable in strain 630 planktonic and biofilm sam-
ples but could not be detected under either condition in R20291.
The ability of the primers used to detect these transcripts was
confirmed using R20291 genomic DNA (data not shown), so it
appears that the expression of multiple pilin genes differs between
630 and R20291 under the conditions examined. In 630, all of the
predicted pilin genes, including pilA1, showed comparable ex-
pression levels under planktonic and biofilm conditions (Fig. 2A).
In R20291, however, pilA1 was upregulated 3-fold by growth in a
biofilm compared to planktonic growth (Fig. 2B). This change
occurs consistently in wild-type cells with no manipulation of
cellular c-di-GMP levels and is likely to represent a biologically
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meaningful change in TFP production during R20291 biofilm for-
mation, suggesting that differential regulation of pilA1 transcrip-
tion contributes to the observed differences in biofilm formation
between 630erm and R20291.
C. difficile R20291 and 630erm are capable of surface mo-
tility. In many bacterial species, TFP have been shown to mediate
surface motility, often as an early step in biofilm development.
Previous work reported that C. difficile is capable of motion on
agar surfaces (51). We thus explored whether C. difficile is capable
of motility on solid surfaces and the potential contribution of TFP.
To do this, liquid cultures of C. difficile 630erm and R20291 were
spotted and allowed to dry on BHIS-1% glucose plates with a
range of agar concentrations, and migration across the surface was
monitored over 5 days. On agar concentrations up to 0.9%, nei-
ther 630erm nor R20291 expanded beyond the boundaries of the
initial spot (Fig. 3A). On 1.2% agar, R20291 expanded from the
inoculation point in dendritic tendrils. The number, length, and
breadth of the tendrils increased with the agar concentration and
surface hardness, reaching an apparent maximum on 1.8% agar.
630erm also migrated from the initial spot, though over a more
limited range of agar concentrations and with no significant ex-
pansion on less than 1.8% agar (Fig. 3A). Thus, C. difficile is capa-
ble of expanding and migrating over agar surfaces in a manner
reliant on surface hardness.
TFP are required for surface motility of C. difficile R20291.
Because TFP participate in surface motility in bacteria such as
Pseudomonas aeruginosa and C. perfringens (36, 52), we hypothe-
sized that TFP contribute to surface motility in C. difficile. To test
this, we assayed the surface motility of R20291, 630erm, and the
pilA1 and pilB1 mutant derivatives by measuring spreading across
1.2% and 1.8% agar daily for 5 days (Fig. 3B and C). We found that
all the strains displayed comparable, limited expansion across
FIG 2 TFP gene transcription in planktonic and biofilm-derived cells. qRT-
PCR was used to measure the transcript levels of predicted structural pilin
genes in planktonic cells from the broth phase of 48-h biofilm cultures (white
bars) and in biofilm-attached cells (gray bars) forC. difficile strains 630 (A) and
R20291 (B). The data are expressed as the fold change in transcript levels in
biofilm-derived cells relative to the planktonic cells, normalized to the refer-
ence gene rpoC. Shown are the means and standard deviations for four biolog-
ically independent samples. The gene names and the corresponding gene num-
bers in the respective strains are listed in Table S4 in the supplemental material.
n.d., not detectable; **, P	 0.01, as determined by two-way ANOVA.
FIG 3 C. difficile migrates across agar surfaces in response to surface hardness. (A) Migration of 630erm and R20291 on BHIS-1% glucose with varying
concentrations of agar (indicated above each panel) after 120 h at 37°C. The scale bars indicate 5 mm. (B and C) Quantification of migration of wild-type and
gene-disrupted 630erm and R20291 on BHIS-1% glucose with 1.2% agar (B) or 1.8% agar (C) over a 5-day period. Five biologically independent spots were
evaluated for each strain at each time point by measuring the diameters in two orthologous directions and using the average value for each spot (see Fig. S3 in the
supplemental material). Shown are the means and standard deviations. n.s., P 0.05; ***, P	 0.001, as determined by one-way ANOVA.
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the softer 1.2% agar. Significant differences between the strains
emerged on the harder 1.8% agar. Disruption of pilA1 or pilB1 in
630erm did not affect motility on 1.8% agar (Fig. 3C). In con-
trast, disruption of pilB1 in R20291 significantly diminished sur-
face motility over 1.8% agar (Fig. 3C), indicating that TFP func-
tion in C. difficile surface motility and play a more prominent role
in R20291.
c-di-GMP promotes TFP-based surface motility. Because c-
di-GMP promotes pilA1 gene expression and TFP biosynthesis,
we next examined the effect of c-di-GMP on surface motility. This
was done by assaying R20291 and 630erm, each with vector or
pDccA to allow c-di-GMP manipulation, for surface motility on
1.2% agar. This agar concentration was initially selected because
R20291 showed some (but not maximal) motility on this surface,
allowing increases or decreases to be observable. Nisin was added
to the agar medium at a range of concentrations up to 5g/ml. For
both the 630erm and R20291 vector controls, the nisin concen-
tration did not affect surface motility (Fig. 4A). 630erm with
pDccA also showed a tendency to form small outgrowths from the
spot of inoculation, which increased modestly with the addition of
nisin (Fig. 4A). In R20291 with pDccA, tendril formation greatly
increased with the nisin concentration, indicating that c-di-GMP
augments surface motility (Fig. 4A). Notably, the c-di-GMP-in-
duced increase in the surface motility of R20291 is dependent on
TFP, as disruption of the pilB1 gene abolished tendril formation
and motility on 1.2% agar, even at elevated c-di-GMP levels (Fig.
4B). On higher (1.5% and 1.8%) concentrations of agar, R20291
and R20291 pilB1::erm with pDccA exhibited more surface expan-
sion independent of nisin (see Fig. S4 in the supplemental mate-
rial). However, the addition of nisin to increase c-di-GMP via
dccA expression further enhanced motility in wild-type R20291
and had minimal effect on R20291 pilB1 (see Fig. S4 in the sup-
plemental material). Thus, c-di-GMP promotes TFP-dependent
surface motility in C. difficile on multiple agar concentrations, and
this phenomenon is more pronounced in R20291.
pilA1 transcription and its regulation by c-di-GMP differ be-
tween C. difficile 630 and R20291. We hypothesized that TFP-
dependent phenotypes differ between 630 and R20291 due to
differences in pilA1 gene expression, potentially in response to
c-di-GMP. To test this, we used qRT-PCR to evaluate pilA1 tran-
script abundance in 630 and R20291, each with vector, pDccA,
or pDccAMUT grown in BHIS-1% glucose medium with 1 g/ml
nisin to early stationary phase. Because the transcript levels of the
reference gene rpoC did not differ significantly between 630 and
R20291 grown under these conditions (see Table S5 in the supple-
mental material), we used rpoC as a reference gene for normaliza-
tion between strains. Furthermore, dccA expression via nisin in-
duction resulted in comparable changes to intracellular c-di-GMP
in 630 and R20291 (see Fig. S3 in the supplemental material), so it
was possible to directly compare pilA1 transcript levels upon c-di-
GMP stimulation. In vector control strains with no manipulation
of c-di-GMP levels, the pilA1 transcript was 26 times more abun-
dant in R20291 than in 630 (Fig. 5A). In 630, induction of dccA
expression with 1 g/ml nisin increased pilA1 transcript abun-
dance 32-fold; in R20291, dccA induction resulted in a modest and
statistically insignificant 2-fold increase (Fig. 5A). Induction of
dccA raises 630 pilA1 transcript abundance to the level seen in
R20291 at native c-di-GMP levels (21). Consistent with the de-
crease in biofilm formation observed in R20291 with pDccAMUT,
expression of dccAMUT and production of a catalytically inactive
diguanylate cyclase reduced pilA1 transcript abundance in both
630 and R20291 compared to the vector control strains, but the
difference was not statistically significant (Fig. 5A). Therefore, c-
di-GMP increases pilA1 transcript abundance, with a greater im-
pact in C. difficile 630, in which basal transcription is low com-
pared to R20291.
c-di-GMP regulates pilA1 expression via the Cdi2_4 ribo-
switch and does not affect promoter activity. As noted above, we
recently reported that pilA1 expression in 630erm is regulated by
c-di-GMP through the riboswitch Cdi2_4 (24). The 5= UTR of
pilA1 is highly conserved between 630/630erm and R20291. The
promoter regions are identical in the two strains, while the 84 bp
of the c-di-GMP binding aptamer contain only two divergent
bases, which are not expected to alter stem-loop formation in the
riboswitch (see Fig. S5 in the supplemental material). To assess
potential differences in promoter and riboswitch activities be-
tween the two C. difficile strains, we constructed a series of four
FIG 4 c-di-GMP stimulates R20291 surface motility in a TFP-dependent
manner. (A) Surface motility of 630erm and R20291, each carrying vector or
pDccA, on BHIS-1% glucose-1.2% agar with increasing concentrations of ni-
sin, as indicated on the left. (B) Surface motility of R20291 and the pilB1
mutant derivative, each bearing vector or pDccA, on BHIS-1% glucose-1.2%
agar and 5g/ml nisin. Representative images taken after 120 h are shown. The
scale bars indicate 5 mm.
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translational fusions of the E. coli gusA (-glucuronidase) gene
under the control of combinations of the native (pilA1) or a het-
erologous (gluD) promoter, with a wild-type or mutant (A70G)
Cdi2_4 riboswitch. C. difficile 630 served as the template for the
four regulatory elements that resulted: PpilA1-UTR, PpilA1-
UTRA70G, PgluD-UTR, and PgluD-UTR
A70G. The plasmid-borne
translational fusions of these regulatory elements to the gusA gene
served as colorimetric reporters in C. difficile.
To evaluate the effects of these regulatory elements on pilA1
transcription at native and elevated levels of c-di-GMP, the four
reporter plasmids were introduced into 630erm::Pcpr-dccA,
which bears dccA in a single copy under the nisin-inducible Pcpr
promoter at an ectopic chromosomal site. We then evaluated
-glucuronidase activity in response to unmodified (without ni-
sin induction) and elevated (with nisin induction) levels of c-di-
GMP. Compared to the absence of nisin, induction of dccA ex-
pression with nisin increased -glucuronidase activity 5-fold in
the strain with PpilA1-UTR-gusA and 4-fold in the strain with
PgluD-UTR-gusA (Fig. 5B). Nisin induction of dccA did not affect
the activities of the strains with either PpilA1-UTR
A70G-gusA or
PgluD-UTR
A70G-gusA, validating the insensitivity of the mutant ri-
boswitch to c-di-GMP (Fig. 5B). Together, these data indicate that
c-di-GMP regulation of pilA1 transcription occurs via the Cdi2_4
riboswitch and does not involve the pilA1 promoter.
Riboswitch activity is conserved between C. difficile strains,
but transcription initiation from the pilA1 promoter is higher
in R20291. We next used the reporters to compare the respective
roles of the pilA1 promoter and the Cdi2_4 riboswitch in activat-
ing downstream gene expression in the two C. difficile strains. We
introduced the PpilA1-UTR-gusA and PpilA1-UTR
A70G-gusA re-
porter fusions, which were derived from the C. difficile 630 se-
quence, into wild-type C. difficile 630erm and R20291. We found
that during exponential growth, the wild-type riboswitch allowed
greater reporter activity than the mutant riboswitch in both
630erm and R20291 strain backgrounds (7.6-fold and 1.8-fold,
respectively), consistent with an inability of c-di-GMP to promote
transcriptional read-through via the mutant Cdi2_4 riboswitch
(Fig. 5C). Both PpilA1-UTR-gusA and PpilA1-UTR
A70G-gusA re-
porters yielded significantly higher activity in the R20291 back-
ground than the 630erm background (45- and 192-fold, respec-
tively). As the reporter uses the pilA1 promoter from 630 in both
strains, this suggests that the differences in -glucuronidase activ-
ity are caused by greater promoter-driven transcription initiation
in R20291.
UPLC-MS indicated that in the absence of experimental ma-
nipulation, 630erm and R20291 have comparable cytoplasmic
levels of c-di-GMP (see Fig. S3 in the supplemental material). To
confirm this, we measured -glucuronidase activity using the
PgluD-UTR-gusA reporter in both strains as an indirect measure of
intracellular c-di-GMP. -Glucuronidase activity was 50%
higher in the R20291 background during exponential growth in
liquid medium, but the difference was not significant, consistent
with the UPLC-MS measurements (Table 1). Together, these re-
sults suggest that differences in c-di-GMP levels are unlikely to be
the sole cause of the observed differences in surface behaviors
between 630erm and R20291. Thus, differences in rates of pro-
moter-based transcription initiation are likely the primary drivers
of the differences in pilA1 expression between the strains.
R20291, but not 630, accumulates more intracellular c-di-
GMP during surface-associated growth than liquid growth.
630erm and R20291 exhibit differences in TFP-mediated behav-
iors after 24 h of biofilm formation or 5 days of growth on agar
plates (Fig. 1 and 3). We utilized the PgluD-UTR-gusA biosensor as
a tool to assess potential differences in c-di-GMP levels between
the two C. difficile strains under these conditions, where direct
FIG 5 pilA1 transcription is regulated by c-di-GMP in 630 and R20291, but
basal transcription is higher in R20291. (A) qRT-PCR was used to measure the
transcript abundances of pilA1 in C. difficile strains 630 and R20291, each with
vector, pDccA, or pDccAMUT, grown in BHIS-1% glucose broth with 1 g/ml
nisin to induce dccA expression. Samples were collected at early stationary
phase. The data were normalized to the rpoC reference gene and expressed
relative to the mean CT (threshold cycle) value for 630 containing vector.
Shown are the means and standard deviations for three biologically indepen-
dent samples. n.s., P  0.05; *, P 	 0.05; **, P 	 0.01, as determined by
two-way ANOVA. (B) Regulation of gene expression by c-di-GMP was as-
sessed using a plasmid-borne gusA transcriptional reporter gene controlled by
the indicated promoter-Cdi2_4 riboswitch combinations. The experiment was
done in 630erm::Pcpr-dccA, which contains the nisin-inducible dccA gene at
an ectopic chromosomal site. The strains were grown to late exponential phase
in BHIS-1% glucose with 0 and 2 g/ml nisin. Shown are the means and
standard deviations for three biologically independent samples. ****, P 	
0.0001, as determined by two-way ANOVA. (C) Differences in pilA1 promoter
activity between 630erm and R20291 were evaluated using a plasmid-borne
gusA translational fusion to the PpilA1 promoter coupled to the 5= UTR with the
wild-type (black) and A70G mutant (gray) Cdi2_4 riboswitch. The strains
were grown to late exponential phase in BHIS-1% glucose. Shown are the
means and standard deviations for six biologically independent samples. **,
P	 0.01; ****, P	 0.0001, as determined by two-way ANOVA.
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measurement using liquid chromatography is not feasible due to
low bacterial numbers. 630erm and R20291 showed no signifi-
cant differences in -glucuronidase activity during exponential
growth or after 24 h of growth in planktonic culture (Fig. 6A). It
was not possible to collect enough biofilm-derived 630erm cells
to assay -glucuronidase activity after 24 h, but we were able to
measure -glucuronidase activity in planktonic and biofilm-de-
rived R20291 cells after 24 h of growth. By comparing -gluc-
uronidase activity in the biofilm-grown cells with that in plank-
tonic cells from the broth phase of the same biofilm cultures, we
found that biofilm-associated bacteria had 33-fold-higher c-di-
GMP-activated reporter activity than planktonic bacteria (Fig.
6A). At periods exceeding 24 h in liquid- and biofilm-grown cells,
the bacterial cultures exhibited a dramatic decrease in viable veg-
etative cells, suggesting cell lysis and/or sporulation (data not
shown). The cell numbers recovered at these times were insuffi-
cient for-glucuronidase activity assays. However, cells remained
viable on agar plates for longer periods, allowing us to assess c-di-
GMP accumulation on agar surfaces of various hardnesses over
the course of 5 days. The -glucuronidase activities in 630erm
cells grown on 0.9%, 1.2%, 1.5%, and 1.8% agar did not differ
significantly at 1, 3, and 5 days, and none of the conditions re-
sulted in increased-glucuronidase activity over time (Fig. 6B). In
contrast, R20291 cells grown under different agar conditions
showed no differences in -glucuronidase activity at 1 or 3 days,
but the 5-day samples showed increased activity compared to the
1- and 3-day samples. The increases were roughly proportional to
the agar concentrations of the substrate medium. After 5 days of
growth, cells grown on 1.5% or 1.8% agar displayed higher
-glucuronidase activity than cells grown on softer 0.9% or 1.2%
agar (Fig. 6C). These data suggest that the intracellular c-di-GMP
concentration of strain R20291 increases over time during growth
on surfaces, while the c-di-GMP levels of strain 630 are relatively
unaffected by surface association.
DISCUSSION
The majority of bacterial life in nature is surface associated, and
bacteria employ a number of mechanisms to sense and respond to
surfaces (53). Some use flagella to sense surfaces, regulating tran-
scription of genes involved in adhesion and motility in response to
changes in the mechanical force necessary for flagellar rotation
(53–58). Similarly, detection of solid biotic or abiotic surfaces by
TFP activates expression of virulence factors and host cell killing
in P. aeruginosa (59). The surface behaviors of C. difficile are
poorly characterized, despite the likelihood that the bacterium
interacts with the host mucosa and/or epithelium during infec-
tion. C. difficile adheres in vitro to monolayers of multiple cell
types, including intestine-derived Caco-2 cells and mucus-secret-
ing HT-29 cells (60–62). C. difficile also adheres to intestinal mu-
cus in vitro and has been found “intimately associated” with the
intestinal mucosa in biopsy specimens taken from a human pa-
tient with antibiotic-induced pseudomembranous colitis (63–65).
In addition,C. difficile can associate with intestinal tissue at sites of
inflammatory damage in both hamsters and mice, suggesting that
the bacteria interact directly with the intestinal epithelium during
infection (66, 67).
TABLE 1 c-di-GMP measurements in 630erm and R20291
C. difficile strain
c-di-GMP level (mol/mg
protein)a
-Glucuronidase activity
(Miller units)b
630erm 1.81
 0.37 21.1
 2.9
R20291 1.49
 0.34 34.4
 23.1
a Intracellular c-di-GMP determined by UPLC-MS of nucleotide extracts of strains
harboring pDccA grown in BHIS-Tm medium with no nisin, normalized to total
protein content. The values are the means
 standard deviations for three independent
samples; P 0.15 (unpaired Student’s t test).
b -Glucuronidase activities of strains harboring the PgluD-UTR-gusA fusion, grown in
BHIS-Tm medium. The values are the means
 standard deviations for six
independent samples; P 0.06 (unpaired Student’s t test).
FIG 6 Growth on surfaces increases intracellular c-di-GMP in C. difficile
R20291. -Glucuronidase activity was evaluated using the PgluD-UTR-gusA
reporter in order to assess relative c-di-GMP levels. (A) -Glucuronidase ac-
tivity was measured in 630erm and R20291 after 6 and 24 h of planktonic
growth in BHIS-Tm medium supplemented with 1% glucose and in R20291
after 24 h of growth in a biofilm. -Glucuronidase activities were compared
between planktonic 630erm and R20291 and between planktonic (Plank.)
and biofilm (BF)-grown R20291 using an unpaired t test. n.d., not detected;
n.s., P  0.05; ***, P 	 0.001. (B and C) -Glucuronidase activity was mea-
sured in 630erm (B) and R20291 (C) after 1, 3, and 5 days of growth on
BHIS-Tm medium supplemented with 1% glucose with the indicated concen-
trations of agar. -Glucuronidase activities between same-age samples were
compared by two-way ANOVA. n.s., P 0.05; *, P	 0.05; **, P	 0.01; ****,
P	 0.0001.
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Adherent pathogens often employ surface motility to disperse
along host tissue to new sites of adherence while remaining in
contact with the epithelium and its associated nutrients (68). C.
difficile strains 630/630erm and R20291 both spread symmetri-
cally from the site of inoculation over 1.8% agar, but only R20291
extends in tendrils over a range of more elastic agar surfaces. As
R20291 tendril formation is enhanced by increases in the c-di-
GMP level and is diminished by disruption of pilB1, it appears that
surface-induced accumulation of c-di-GMP and subsequent TFP
formation result in the greater surface motility observed in
R20291. It is important to note that disruption of pilB1 does not
completely eliminate motility in wild-type R20291, but it prevents
R20291 with pDccA from increasing its motility in response to
increased c-di-GMP. C. difficile encodes a second pilB orthologue,
pilB2. Some functional redundancy may permit some surface mo-
tility in the absence of pilB1 (see Table S4 in the supplemental
material) (50). As disruption of TFP genes does not affect
630erm spreading over high-percentage agar, it is possible that
cells on very hard surfaces spread passively by sliding away from
sites of cell division.
Our findings suggest that C. difficile surface motility is influ-
enced by the hardness of the substratum; the bacterium appears
incapable of moving across very soft agar surfaces, although c-di-
GMP stimulation of TFP synthesis appears to increase the range of
substrata on which the R20291 strain can spread. The minimum
surface hardness required for motility by either C. difficile strain is
1% agar, which has an elastic modulus, or ability to deform in
response to pressure, of roughly 10 kPa (69). R20291 is more adept
than 630/630erm at spreading upon 1 to 2% agar. Agar percent-
ages between 1 and 2% represent the spectrum between healthy
intestinal tissue, which has an elastic modulus of 10 kPa, and in-
testinal tissue stiffened by inflammation, which has an elastic
modulus of 25 kPa (69–71). Notably, the inflammation caused by
C. difficile infection makes the colon wall harder, causing it to
thicken from 6 to 8 mm to 22 to 32 mm and to stiffen significantly
(72). We speculate that this inflammatory stiffening of the intes-
tinal epithelium following C. difficile attachment promotes bacte-
rial motility and dispersal across the harder surface. Thus, R20291
may spread across host tissue more efficiently, or earlier during
the course of an infection, than historical C. difficile, potentially
contributing to its higher virulence.
Biofilms play a role in the establishment of persistent infection
by a number of pathogens (73). C. difficile cells removed from
biofilms exhibit reduced susceptibility to vancomycin, an antibi-
otic commonly used to treat C. difficile infection in humans, sug-
gesting that biofilm formation within a host could contribute to
the difficulty of treating C. difficile infections (7, 43, 73–76). Here,
we show that c-di-GMP regulates biofilm formation in C. difficile
strains 630/630erm and R20291 via control of TFP formation.
Not only does R20291 display greater biofilm formation than 630/
630erm, TFP (pilA1) gene transcription is significantly higher in
R20291 than in 630/630erm. The Cdi2_4 riboswitch promotes
pilA1 transcript elongation in response to c-di-GMP binding, so
we considered the possibility that R20291 has higher basal levels of
c-di-GMP, leading to greater expression of pilA1. However, direct
measurements show that the strains have comparable intracellular
concentrations of c-di-GMP during growth in broth culture. This
result was corroborated by studies using a c-di-GMP biosensor
consisting of the constitutive gluD promoter, the Cdi2_4 c-di-
GMP riboswitch, and a gusA transcriptional reporter, which
showed comparable activities in R20291 and 630/630erm during
growth in broth culture.
Using the PgluD-UTR-gusA fusion as a c-di-GMP biosensor, we
observed a modest but significant increase in intracellular c-di-
GMP during growth of R20291 in a biofilm and on agar surfaces,
which was more pronounced on harder agar surfaces. The degree
of c-di-GMP fluctuation in C. difficile is unknown, so the biolog-
ical significance of an approximately 2-fold increase in c-di-GMP
during growth on harder surfaces is unclear. Nonetheless, this
increase coincides with TFP-dependent motility and may reflect
the extent of c-di-GMP increases in vivo. No evidence of a change
in c-di-GMP was observed for 630/630erm grown under any of
the described conditions. Consistent with this, R20291, but not
630/630erm, upregulates pilA1 transcription during growth in a
biofilm. Unfortunately, 630/630erm does not yield enough bio-
mass in biofilms to allow estimation of c-di-GMP levels in bio-
film-derived cells using either -glucuronidase assays or UPLC-
MS. However, the fact that pilA1 transcription is upregulated
during biofilm formation on a surface in R20291 but not 630/
630erm suggests that R20291 responds more strongly than 630/
630erm to the physical properties of its substratum. Together,
these findings suggest that a surface-induced increase in intracel-
lular c-di-GMP, which increases read-through transcription of
the pilA1 transcript, promotes R20291 TFP-mediated spread
across and attachment to surfaces physically comparable to those
it would encounter in an infected host.
Using reporters under the control of the pilA1 promoter re-
gion, which is identical in R20291 and 630/630erm, we deter-
mined that pilA1 promoter activity is higher in R20291. This dif-
ference in pilA1 expression between the strains is independent of
the c-di-GMP riboswitch. We propose that an unidentified trans-
acting regulatory factor mediates the higher pilA1 transcription
seen in R20291. Such a regulator may be differentially produced or
active in the two strains, and/or the regulator(s) controlling pilA1
transcription initiation may not be fully conserved. Transcrip-
tional analyses revealed that hundreds of conserved genes are dif-
ferentially expressed by 630 and R20291, so it is clear that differ-
ences in genetic regulation between the two strains will be an
important subject for future studies (16). It appears that promot-
er-driven transcription of pilA1 differs between the two strains,
while control of pilA1 transcript elongation via the c-di-GMP ri-
boswitch is conserved between 630/630erm and R20291. Thus,
R20291 may display greater c-di-GMP-induced, TFP-mediated
surface behaviors because it produces more pilA1 transcripts that
can respond to increases in intracellular c-di-GMP and, likewise,
upregulates c-di-GMP production during growth on surfaces. It is
unclear how large a change in the c-di-GMP concentration is re-
quired to trigger an increase in pilus gene expression and mediate
TFP-dependent processes or if such a threshold differs between
the two strains.
c-di-GMP consistently represses flagellum-mediated motility
in diverse species, such asP. aeruginosa andB. subtilis, and appears
to repress TFP-based twitching motility in P. aeruginosa (20, 77–
79). However, we have found that c-di-GMP promotes TFP-de-
pendent surface motility in C. difficile. As TFP in Gram-positive
bacteria have only recently been identified, it is possible that their
regulation and functions differ from those in Gram-negative bac-
teria (34, 35, 51). c-di-GMP promotes TFP formation and TFP-
dependent biofilm formation and surface motility in C. difficile,
mediating the organism’s interactions with surfaces. The discov-
Purcell et al.
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ery that R20291 is more responsive to surfaces than 630/630erm
makes it clear that the differences between historical and epidemic
strains must be evaluated under multiple conditions. As the inter-
actions of C. difficile with host epithelial surfaces become better
characterized, it may be revealed that surface sensing contributes
to C. difficile virulence and persistence.
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